A Chemoenzymatic Approach to Accessing Novel Isoprenoid Scaffolds
获取新型类异戊二烯支架的化学酶方法
基本信息
- 批准号:10543814
- 负责人:
- 金额:$ 29.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Isoprenoids represent a diverse class of compounds with a broad range of applications in medicine and industry.
Their extraction from natural sources is both challenging and potentially harmful to the environment, while the
enormous structural complexity of many isoprenoids makes traditional chemical synthesis nontrivial. Modern
metabolic engineering and synthetic biology approaches have overcome some of these difficulties, but issues
related to metabolic flux and the limited availability of the universal isoprenoid precursors complicate their
widespread implementation. The artificial pathways developed thus far have been solely focused on synthesizing
dimethylallyl and isopentenyl diphosphates and require additional enzymes for the generation of polyprenyl-
diphosphates (polyprenyl-PPs). Thus, the primary objective of this proposal is to develop an efficient strategy for
the synthesis of both natural and unnatural (poly)prenyl-PPs for downstream applications. This will be achieved
using two complementary methods: i) employing undecaprenol kinases and isopentenyl phosphate kinases; and
ii) employing hydroxyethylthiazole kinase, isopentenyl phosphate kinases, and farnesyl diphosphate synthase.
Additionally, the two methods will work in conjunction with isoprenoid methylatransferases to incorporate
additional diversity into the polyprenyl-PPs. The proposed studies include: i) structural and functional assessment
of selected enzymes, ii) catalyst engineering, and iii) optimization of coupled in vitro and in vivo platforms for
the generation of diversified libraries of select natural products. We expect these studies to generate: i) rules and
concepts to advance knowledge on structure-activity relationships in selected classes of enzymes; ii) an optimized,
enzyme-coupled platform to generate diversified substrates and isoprenoids; and iii) novel isoprenoid analogs
with potential therapeutic applications. Thus, the proposed work will offer unprecedented access to uniquely
bioactive isoprenoid libraries not readily accessible via traditional methods, and it stands to deepen our
fundamental understanding of four enzyme classes while also developing them into useful biocatalysts.
项目摘要
类异型代表着各种各样的化合物,在医学和工业中使用了广泛的应用。
它们从自然来源中提取既有挑战性又可能对环境有害,而
许多类异戊二烯的巨大结构复杂性使传统的化学合成无繁殖。现代的
代谢工程和合成生物学方法已经克服了其中一些困难,但问题
与代谢通量和普遍类异丙类动物前体的有限可用性有关使其复杂性有关
广泛的实现。迄今为止开发的人工途径仅专注于合成
二甲基烯丙基和异戊烯基二磷酸盐,需要额外的酶以产生聚丙烯基 -
双磷酸盐(聚丙烯基-PP)。因此,该提案的主要目的是制定有效的策略
在下游应用中综合自然和非自然(多年)前PPP。这将被实现
使用两种互补方法:i)采用异孕醇激酶和异戊烯基磷酸激酶;和
ii)采用羟基硫唑激酶,异戊烯基磷酸激酶和Farnesyl二磷酸合酶。
此外,这两种方法将与异澳甲基转移酶结合起来合并
聚丙基培养基的额外多样性。拟议的研究包括:i)结构和功能评估
选定的酶,ii)催化剂工程和iii)优化体外和体内平台的耦合
精选天然产品的多元化库产生。我们希望这些研究能够产生:i)规则和
促进选定酶类中结构活性关系知识的概念; ii)优化,
酶耦合平台,以产生多样化的底物和类异丙裔; iii)新型类似物类似物
具有潜在的治疗应用。因此,拟议的工作将提供前所未有的访问权限
生物活性类异丙库不容易通过传统方法访问,它可以加深我们
对四种酶类别的基本了解,同时也将它们发展为有用的生物催化剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Shanteri Singh的其他基金
A Chemoenzymatic Approach to Accessing Novel Isoprenoid Scaffolds
获取新型类异戊二烯支架的化学酶方法
- 批准号:1058236410582364
- 财政年份:2022
- 资助金额:$ 29.11万$ 29.11万
- 项目类别:
A Chemoenzymatic Approach to Accessing Novel Isoprenoid Scaffolds
获取新型类异戊二烯支架的化学酶方法
- 批准号:1036491410364914
- 财政年份:2022
- 资助金额:$ 29.11万$ 29.11万
- 项目类别:
Development of chemoenzymatic platform for facile synthesis of alkyl-pyrophosphate analogs
开发化学酶平台以方便合成烷基焦磷酸类似物
- 批准号:1018207610182076
- 财政年份:2020
- 资助金额:$ 29.11万$ 29.11万
- 项目类别:
相似海外基金
Actions of spiropyrimidinetriones against bacterial type II topoisomerases
螺嘧啶三酮对细菌 II 型拓扑异构酶的作用
- 批准号:1075047310750473
- 财政年份:2023
- 资助金额:$ 29.11万$ 29.11万
- 项目类别:
Development of Selective Oxidative Biocatalytic Methods
选择性氧化生物催化方法的发展
- 批准号:1060679810606798
- 财政年份:2023
- 资助金额:$ 29.11万$ 29.11万
- 项目类别:
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
心力衰竭的新型疗法:修饰的水溶性 Caveolin-1 支架结构域肽,具有改进的药物开发特性
- 批准号:1059965410599654
- 财政年份:2023
- 资助金额:$ 29.11万$ 29.11万
- 项目类别:
Enzymology of Bacteroides short and branched chain fatty acid metabolism
拟杆菌短链和支链脂肪酸代谢的酶学
- 批准号:1065150510651505
- 财政年份:2023
- 资助金额:$ 29.11万$ 29.11万
- 项目类别:
Designing chemoenzymatic approaches to biologically active molecules enabled by enzyme library screening
通过酶库筛选设计生物活性分子的化学酶方法
- 批准号:1072358210723582
- 财政年份:2023
- 资助金额:$ 29.11万$ 29.11万
- 项目类别: